Original Research
Published on 13 Feb 2026
Thromboembolic adverse events associated with TPO-RA in ITP treatment: a pharmacovigilance analysis of the FDA Adverse Event Reporting System
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
- 141 views